On September 8, 2023, the Department of Treasury (the Treasury) and the Internal Revenue Service (the IRS) unveiled the Notice 2023-63. This notice displays the Treasury and the IRS’s intent to roll out proposed regulations addressing the application of Section 174 of the tax code. The legislation, known as the Tax Cuts and Jobs Act, underwent amendments in 2017. One significant change was the elimination of the provision that allowed taxpayers to deduct Research and Experimental (R&E) expenditures.
This alteration in Section 174 now requires taxpayers to capitalize and amortize specified R&E expenses. The interim guidance on how to capitalize and amortize these R&E expenses comes as a necessary response from these changes.
The IRS’s renewed regulations intend to provide clarity for legal professionals and corporate entities dealing with R&E expenditures. Readers interested in understanding the finer details of the IRS’s interim guidance can find it at JD Supra. The interim guidance was developed under the guidance of law firm Wilson Sonsini Goodrich & Rosati.
The anticipation around these regulations underscores the importance of clear, well-communicated tax codes and regulations in the wake of legislative changes affecting industries reliant on research and development. It is vital for these corporations, their legal teams, and associated parties to remain up-to-date with these changes and the resulting guidance, ensuring that they remain compliant with ever-evolving tax obligations.